{"nct_id":"NCT03382600","title":"Safety and Efficacy of Pembrolizumab (MK-3475) in Combination With TS-1+Cisplatin or TS-1+Oxaliplatin as First Line Chemotherapy in Gastric Cancer (MK-3475-659/KEYNOTE-659)","status":"COMPLETED","status_verified_date":"2024-05","start_date":"2018-03-26","start_date_type":"ACTUAL","primary_completion_date":"2021-05-30","primary_completion_date_type":"ACTUAL","completion_date":"2021-05-30","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["MRK"]}